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A B S T R A C T
Accumulation of the misfolded prion protein, PrPSc in the central nervous system (CNS) is strongly linked
to progressive neurodegenerative disease. For many transmissible spongiform encephalopathies (TSEs),
peripheral lymphoid tissue is an important site of PrPSc ampliﬁcation but without gross immunological
consequence. Susceptible VRQ homozygous New Zealand Cheviot sheep were infected with SSBP/
1 scrapie by inoculation in the drainage area of the prescapular lymph nodes. The earliest time that PrPSc
was consistently detected by immunohistology in these nodes was D50 post infection. This
transcriptomic study of lymph node taken before (D10) and after (D50) the detection of PrPSc, aimed
to identify the genes and physiological pathways affected by disease progression within the nodes as
assessed by PrPSc detection. Affymetrix Ovine Gene arrays identiﬁed 75 and 80 genes as differentially-
expressed at D10 and D50, respectively, in comparison with control sheep inoculated with uninfected
brain homogenate. Approximately 70% of these were repressed at each time point. RT-qPCR analysis of
seven genes showed statistically signiﬁcant correlation with the array data, although the results for IL1RN
and TGIF were different between the two technologies. The ingenuity pathway analysis (IPA) and general
low level of repression of gene expression in lymphoid tissue, including many inﬂammatory genes,
contrasts with the pro-inﬂammatory and pro-apoptotic events that occur within the CNS at equivalent
stages of disease progression as assessed by PrPSc accumulation.
ã 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Sheep scrapie is a transmissible spongiform encephalopathy
(TSE), a group of fatal neurodegenerative diseases of the central
nervous system (CNS). A key feature of TSEs is the conversion of the
host-encoded prion protein PrPC to disease-associated PrPSc
(Prusiner, 1982); the replication of pathological PrPSc from
physiological PrPC is a critical component of the disease (Prusiner
et al.,1999). The essential role of PrPC in TSE disease is conﬁrmed by
the resistance of PrPnull mice to disease (Bueler et al., 1993); by the
reciprocal relationship of PrP gene (PRNP) copy number and
incubation period (Bueler et al., 1993; Manson et al., 1994), and by
the fact that resistance to sheep scrapie is inﬂuenced by
polymorphisms of PRNP at codons 136 (V or A), 154 (R or H)
and 171 (R or Q) (Goldmann et al., 1994). With SSBP/1 scrapie in
Cheviot sheep, VRQ homozygotes have the shortest incubation
period (Houston et al., 2002).* Corresponding author at: The Roslin Institute & R(D)SVS, University of
Edinburgh, Easter Bush, Midlothian EH25 9RG, UK. Fax: +44 131 651 9107
E-mail address: john.hopkins@ed.ac.uk (J. Hopkins).
http://dx.doi.org/10.1016/j.vetmic.2015.10.013
0378-1135/ã 2015 The Authors. Published by Elsevier B.V. This is an open access articThe CNS is the major target organ for TSE disease and
neurodegeneration is associated with the accumulation of PrPSc
within neurons (Mallucci et al., 2003). Many TSE agents, including
natural sheep scrapie, are associated with replication of infectivity
in peripheral lymphoid tissue prior to the invasion of the CNS
(Mabbott and Bruce, 2003). PrPSc replicates in follicular dendritic
cells (FDC) in spleen and lymph node germinal centres (Jeffrey
et al., 2000; McCulloch et al., 2011) and interference of this
prolongs the incubation period. However, in contrast to neurons,
PrPSc replication by FDC does not lead to their degeneration or the
inhibition of gross immunological functions (Heikenwalder et al.,
2005).
The effects of PrPSc accumulation on the CNS transcriptome has
been investigated in several different species, including mice
(Xiang et al., 2004), cattle (Almeida et al., 2011), sheep (Filali et al.,
2012; Gossner and Hopkins, 2014) and humans (Tian et al., 2013)
with the aim of identifying genes associated with TSE disease
progression. Similar analysis of secondary lymphoid tissues is so
far limited to two sheep studies; an investigation on mesenteric
lymph node in natural scrapie (Filali et al., 2014) and our
preliminary study (Gossner et al., 2011b) on SSBP/1 scrapie. The
earliest time that PrPSc was consistently detected byle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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prescapular lymph node (PSLN) draining the site of scrapie
inoculation; and microarray analysis of PSLN and spleen at
D75 linked repression of inﬂammation with the accumulation of
PrPSc. This current study exploits the same model to compare,
using the new Affymetrix Ovine Gene 1.1 ST whole-genome
expression array and by RT-qPCR, the effects of scrapie infection on
the transcriptome of the PSLN early after infection (D10) and after
the immunohistochemical detection of PrPSc (D50). In this way we
aim to identify how scrapie infection and/or PrPSc affect the
molecular physiology of secondary lymphoid tissue; and to
compare the events in this tissue to the CNS at equivalent stages
of disease progression as assessed by PrPSc accumulation.
2. Materials and methods
2.1. Animals and experimental design
Animals, infections and tissues have been described in detail
previously (Gossner et al., 2011a,b). Brieﬂy, Cheviot sheep with
PRNP homozygous genotype VRQ/VRQ (Houston et al., 2002) were
inoculated subcutaneously in the drainage area of the PSLNs with
either SSBP/1 brain homogenate (infected) or similarly prepared
scrapie-negative brain homogenate; both brain homogenates
contained PrP of both VRQ and ARQ genotypes. Three infected
and two uninfected controls were killed at 10 days (D10) and
50 days (D50) post infection. Animal experiments were approved
by BBSRC Institute for Animal Health Ethical Review Committee
and conducted under an Animals (Scientiﬁc Procedures) Act
1986 Project Licence.
2.2. Sample collection and total RNA isolation
Tissues were removed post-mortem, dissected into blocks and
submerged in RNAlater1 (Ambion) incubated at 4 C overnight and
stored at 80 C. Total RNA was isolated using the RiboPureTM RNA
Puriﬁcation Kit (Ambion, Huntingdon, UK) with DNase I digestion.
RNA quality and integrity was assessed using the Agilent RNA
6000 Nano kit on the Agilent 2100 Bioanalyzer and quantiﬁed with
a NanoDrop ND-1000 spectrophotometer.Table 1
Signiﬁcantly increased differentially-expressed genes at D10.
Gene Gene name 
IFI6 Interferon, alpha-inducible protein 6 
ADM Adrenomedullin 
ZNF347 Zinc ﬁnger protein 347 
XAF1 XIAP associated factor 1 
OR5S1P Olfactory receptor, family 5, subfamily S, membe
GCSH Glycine cleavage system protein H (aminomethy
MOGAT3 Monoacylglycerol O-acyltransferase 3 
ZBTB16 Zinc ﬁnger and BTB domain containing 16 
FKBP14 FK506 binding protein 14, 22 kDa 
NUDT15 Nudix (nucleoside diphosphate linked moiety X)
S100A5 S100 calcium binding protein A5 
ESRP2 Epithelial splicing regulatory protein 2 
FAM171B Family with sequence similarity 171, member B 
OR10H1 Olfactory receptor, family 10, subfamily H, memb
SERBP1 SERPINE1 mRNA binding protein 1 
IER3 Immediate early response 3 
RASGRF2 Ras protein-speciﬁc guanine nucleotide-releasing
ZC3H12B Zinc ﬁnger CCCH-type containing 12B 
GJA3 Gap junction protein, alpha 3, 46kDa 
IGFBPL1 Insulin-like growth factor binding protein-like 1 
DMXL2 Dmx-like 2 
MTERFD1 MTERF domain containing 1 
IL1RN Interleukin 1 receptor antagonist 
Genes with fold change (FC)  1.5 fold and adjusted p value of 0.05.2.3. RNA ampliﬁcation and microarray hybridization
Transcriptome analysis was by Affymetrix Ovine Gene 1.1 ST
arrays, which consist of 508,538 oligomers (25 mer) covering
22,047 genes. These are complementary to approximately
635 bases per gene and cover all exons of each annotated
transcript of the Oar v2 sheep genome assembly. Sense-strand
cDNA was generated from 0.5 mg of total RNA and subjected to two
rounds of ampliﬁcation using the Ambion1WT Expression Kit. The
cDNA was biotin labelled and fragmented using the Affymetrix
GeneChip1 WT Terminal Labelling and Hybridization kit. Biotin-
labelled fragments of cDNA (5.5 mg) were hybridized to the array
plates using the appropriate Hyb-Wash-Scan protocol with
reagents from the Affymetrix Gene Titan Hyb Wash Stain kit.
After hybridization the plates were washed, stained and scanned
by the Imaging Station of the GeneTitan System. The Affymetrix1
GeneChip1 Command Console1 Software (v3.0.1) was used to
generate array images and the resulting Affymetrix intensity ﬁles
(CEL ﬁles), along with the initial QC analysis.
2.4. Microarray data analysis
The CEL ﬁles were imported into Partek Genomics Suite 1
software, version 6.13.0213 (Copyrightã 2014; Partek Inc., St. Louis,
MO, USA.) and data were analyzed at the gene-level using the mean
expression of all exons of a gene. Background correction was
performed using the robust multiarray average (RMA) algorithm,
with quantile normalization, median polish probe summarization,
and log2 probe transformation. Differentially-expressed genes
were identiﬁed by analysis of variance (ANOVA), genes with a fold
change >1.5 or <1.5, and p value > 0.05 were retained. Hierarchi-
cal clustering was performed on signiﬁcant genes, with the data
normalized to a mean of zero and scaled to standard deviation of
one using Partek. Signiﬁcant genes were annotated based on
similarity scores in BLASTN comparisons of Affymetrix Transcript
cluster sequences against mRNA sequences in GenBank. The array
data have been deposited in ArrayExpress database (www.ebi.ac.
uk/arrayexpress) accession number E-MTAB-2327.p value FC
0.0422 2.62
0.0482 2.30
0.0282 2.04
0.0143 1.97
r 1 pseudogene 0.0225 1.87
l carrier) 0.0496 1.85
0.0309 1.78
0.0366 1.76
0.0495 1.73
-type motif 15 0.0353 1.73
0.0040 1.69
0.0449 1.66
0.0279 1.64
er 1 0.0348 1.63
0.0265 1.62
0.0151 1.60
 factor 2 0.0234 1.59
0.0049 1.58
0.0122 1.57
0.0218 1.57
0.0107 1.56
0.0302 1.54
0.0337 1.52
Table 2
Signiﬁcantly repressed differentially-expressed genes at D10.
Gene Gene name p value FC
ASZ1 Ankyrin repeat, SAM and basic leucine zipper domain 1 0.0140 2.56
SEPT5 Septin 5 0.0056 2.31
Ovar-DYA O. aries DNA for MHC class II DYA exon 3 (second domain) 0.0443 2.08
RAB26 RAB26, member RAS oncogene family 0.0428 2.01
ZNF391 Zinc ﬁnger protein 391 0.0347 1.90
HNF4A Hepatocyte nuclear factor 4, alpha 0.0421 1.81
BRINP1 Bone morphogenetic protein/retinoic acid inducible neural-speciﬁc 1 0.0157 1.78
LMF1 Lipase maturation factor 1 0.0379 1.76
HTR3A 5-Hydroxytryptamine (serotonin) receptor 3A, ionotropic 0.0388 1.73
CYP3A5 Cytochrome P450, family 3, subfamily A, polypeptide 5 0.0295 1.73
MOGAT2 Monoacylglycerol O-acyltransferase 2 0.0078 1.72
CLDN10 Claudin 10 0.0365 1.71
ACOT4 Acyl-CoA thioesterase 4 0.0022 1.71
OR8A1 Olfactory receptor, family 8, subfamily A, member 1 0.0259 1.70
LOC101907318 LOC101907318 [Bos taurus] 0.0186 1.68
DNAJB3 DnaJ (Hsp40) homolog, subfamily B, member 3 0.0003 1.67
NEFL Neuroﬁlament, light polypeptide 0.0316 1.66
RPL19 Ribosomal protein L19 0.0430 1.66
FZD5 Frizzled class receptor 5 0.0493 1.65
MAG Myelin associated glycoprotein 0.0210 1.64
HIST1H2AG Histone cluster 1, H2ag 0.0122 1.63
CXorf66 Chromosome X open reading frame 66 0.0240 1.61
PRAMEF12 PRAME family member 12 0.0210 1.61
TRMT2A tRNA methyltransferase 2 homolog A (S. cerevisiae) 0.0487 1.61
KRTAP9-1 Keratin associated protein 9-1 0.0119 1.61
KRT35 Keratin 35 0.0484 1.60
PHOSPHO1 Phosphatase, orphan 1 0.0057 1.60
Gene Gene name p value FC
OR10G9 Olfactory receptor, family 10, subfamily G, member 9 0.0362 1.59
LRRC15 Leucine rich repeat containing 15 0.0059 1.59
OR1P1 Olfactory receptor, family 1, subfamily P, member 1 0.0133 1.58
PARD6B par-6 family cell polarity regulator beta 0.0030 1.58
KCNV1 Potassium channel, subfamily V, member 1 0.0036 1.58
TMPRSS6 Transmembrane protease, serine 6 0.0367 1.56
OR5B2 Olfactory receptor, family 5, subfamily B, member 2 0.0204 1.56
NEGR1 Neuronal growth regulator 1 0.0325 1.55
COBL Cordon-bleu WH2 repeat protein 0.0235 1.55
OR9K2 Olfactory receptor, family 9, subfamily K, member 2 0.0032 1.55
ZNF398 Zinc ﬁnger protein 398 0.0380 1.55
TRHDE Thyrotropin-releasing hormone degrading enzyme 0.0119 1.54
MKRN1 Makorin ring ﬁnger protein 1 0.0318 1.54
GTPBP6 GTP binding protein 6 (putative) 0.0166 1.54
ATCAY Ataxia, cerebellar, Cayman type 0.0009 1.54
ATP8A2 ATPase, aminophospholipid transporter, class I, type 8A, member 2 0.0068 1.54
GPR68 G protein-coupled receptor 68 0.0462 1.53
ZDHHC19 Zinc ﬁnger, DHHC-type containing 19 0.0022 1.53
OR8B3 Olfactory receptor, family 8, subfamily B, member 3 0.0457 1.53
PGA4 Pepsinogen 4, group I (pepsinogen A) 0.0001 1.53
SLC7A9 Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 0.0213 1.52
LIPN Lipase, family member N 0.0218 1.51
CCNI2 Cyclin I family, member 2 0.0057 1.51
RPL10 Ribosomal protein L10 0.0007 1.51
KHDRBS3 KH domain containing, RNA binding, signal transduction associated 3 0.0415 1.50
Genes with fold change (FC) 1.5 fold and adjusted p value of 0.05.
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Network analysis was performed through the use of QIAGEN’s
Ingenuity Pathway Analysis (IPA1, QIAGEN Redwood City, www.
qiagen.com/ingenuity) to increase conﬁdence in the observations of
differentially-expressed genes by correlation with biological path-
ways. This process also allowed the identiﬁcation of putative key
functional elements within the networks of differentially-expressed
genes. The network interaction of the focused genes in the network is
based on their connectivity in ingenuity knowledge base.
2.6. Quantitative real time RT-PCR (RT-qPCR)
Relative quantiﬁcation of mRNA expression was conducted by
RT-qPCR, using the FastStart Universal SYBR Master (Roche AppliedScience) reaction mix. First strand cDNA synthesis was performed
with 1 mg of total RNA using 0.5 mg oligo (dT)15 primer (Promega)
and SuperScript1 II Reverse Transcriptase (Invitrogen) in a 20 ml
ﬁnal volume using the manufacturer’s recommended standard
protocol.
RT-qPCR analysis wasperformedusinga Rotor-GeneTMQ (Qiagen,
Crawley, UK) with reactions prepared using a CAS-1200TM Precision
Liquid Handling System (Qiagen). All reactions were performed in
ﬁnal volume of 15 ml and ‘no template’ controls were included for
each primer pair. Gene speciﬁc primers sequences and PCR
conditions for qPCR analysis are listed in Table S1. The ampliﬁcation
proﬁle consisted of 10 min at 95 C, followed by 40 cycles of gene-
speciﬁc cycling conditions (Table S1), followed by a dissociation
curve analysis. The cycle threshold value (Cq) was determined using
the Rotor-Gene Q Software version 2.3.1 (build 49).
Table 3
Signiﬁcantly increased differentially-expressed genes at D50.
Gene Gene name p value FC
TMEM116 Transmembrane protein 116 0.0342 1.74
HIST1H2AD Histone cluster 1, H2ad 0.0075 1.73
LMO7 LIM domain 7 0.0287 1.72
ZNF471 Zinc ﬁnger protein 471 0.0050 1.70
GPR123 G protein-coupled receptor 123 0.0437 1.67
CYP4F8 Cytochrome P450, family 4, subfamily F, polypeptide 8 0.0147 1.67
ABCB6 ATP-binding cassette, sub-family B (MDR/TAP), member 6 0.0003 1.65
NAT1 N-acetyltransferase 1 (arylamine N-acetyltransferase) 0.0015 1.65
ZNF419 Zinc ﬁnger protein 419 0.0068 1.59
MRPL13 Mitochondrial ribosomal protein L13 0.0223 1.59
MAL mal, T-cell differentiation protein 0.0487 1.58
MAGIX MAGI family member, X-linked 0.0348 1.55
LYPLA2 Lysophospholipase II 0.0454 1.54
CYCS Cytochrome c, somatic 0.0148 1.53
RPL29 Ribosomal protein L29 0.0095 1.52
ANKRD34A Ankyrin repeat domain 34A 0.0379 1.51
HMGB1 High mobility group box 1 0.0279 1.50
VNN2 Vanin 2 0.0204 1.50
Genes with fold change (FC)  1.5 fold and adjusted p value of  0.05.
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product and sequence analysis was used to conﬁrmed speciﬁcity of
primer pairs. The linearity and efﬁciency of RT-qPCR ampliﬁcation
was determined for each primer pair (Table S1) using a standard
curve generated by a dilution series of a pool of sample cDNAs.
2.7. RT-qPCR data analysis
The data analysis was based on a reaction efﬁciency-corrected
modiﬁed comparative Cq method (DDCq method) with gene
expression normalized to the geometric mean of the reference
genes SDHA and YWHAZ using the GenEx software version
5.3.4.157 (www.multid.se). To determine signiﬁcant differences in
gene expression between uninfected and SSBP/1 infected time
points (D10 and D50), the log2 transformed data were compared
using an unpaired t-test (2-tailed) within GenEx, p values < 0.05
were regarded as statistically signiﬁcant. The Spearman’s rank
correlation coefﬁcient was performed using GraphPad Prism
version 6.05 for Windows (GraphPad Software, La Jolla California
USA, www.graphpad.com).
3. Results
3.1. Differential gene expression at D10 and D50
Array analysis identiﬁed 75 genes that showed signiﬁcant
difference, fold change 1.5 and adjusted p value  0.05, in the
D10 vs. uninfected control (C) comparison; 23 were signiﬁcantly
increased (Table 1) and 52 were repressed (Table 2). At D50,
80 genes were differentially expressed, 18 were increased (Table 3)
and 62 repressed (Table 4). No genes were common in the two
comparisons, D10 vs. C and D50 vs. C; neither were there any
signiﬁcantly expressed genes (fold change  1.5 and p  0.05) in the
direct comparison of the two infected groups, D10 vs. D50
(Table S2 and Table S3). The general repression of gene expression
after infection is emphasized by heat maps for D10 (Fig. S1A) and
D50 (Fig. S1B); in addition, they show the consistency of data from
the individual sheep within the infected and control groups. The
most up-regulated genes (and p  0.05) based on expression fold
change included IFI6 (+2.62 fold) and ADM (+2.30) at D10 and
GPR123 (+1.67) at D50. The most repressed included SEPT5 (2.31)
and Ovar-DYA (2.08) at D10; and MOXD1 (4.38), CDH26 (2.44)
and CAMP (2.43) at D50. The data were also analysed in relation to
fold change without regard to p value (Table S4), and this showedthat HLA-DQA1 was the most differentially-expressed gene that
increased 15.91 fold (p = 0.152) at D10 and 7.93 fold (p = 0.266) at
D50. This list supports some of the data in Tables 1, S2 and S3,
including a 1.67 fold repression of MOXD1 (p = 0.302) at D10
(4.38 fold at D50); a 1.54 fold increase in IFI6 (p = 0.291) at D50
(+2.26 fold at D10) and a 2.54 repression of a second cathelicidin,
CATHL1B also at D50. In addition, two inﬂammatory chemokines,
CCL26 and CCL3L1 were repressed (2.77 and 2.84 fold) and
AICDA was 2.76 fold increased at D50.
3.2. Ingenuity pathway analysis
Ingenuity pathway analysis (IPA) was used to help characterize
how differentially-expressed genes interact and affect the biologi-
cal processes leading to the development of pathology in the SSBP/
1 model of sheep scrapie in peripheral lymphoid tissue. The top
Diseases and Disorders Bio Functions (Table 5) at D10 include
‘Gastrointestinal disease’ with 9 genes and the highest p value of
5.06  104, ‘Organismal injury and abnormalities (11 genes,
p = 5.06  104) and ‘Neurological disease’ (16 genes, p value
5.06  104). At D50 the top Diseases and Disorders Bio Functions
include ‘Neurological disease’ (8 genes p = 1.74 104), ‘Inﬂamma-
tory response (5 genes, p = 3.24 104), ‘Immunological disease’
(13 genes, p = 1.97  103) and ‘Inﬂammatory disease’ (13 genes,
p = 1.97  103).
3.3. RT-qPCR analysis
Fold-change RT-qPCR of seven selected genes was used as
independent validation of the microarray data. The relative
expression levels of the genes in the D10, D50 and C groups is
shown in Fig. 1 and the direct comparison of the fold changes
obtained by Affymetrix arrays and by RT-qPCR is shown in Table 6.
Spearman’s rank correlation analysis of the fold-change data
shows correlation coefﬁcients (r) of 0.6 (p = 0.17) for D10 and 0.94
(p = 0.005) for D50, and r = 0.6 (p = 0.01) for the combined D10/
D50 data for all seven genes. RT-qPCR for ADM,CDH26, HMGB1, IFI6
and MOXD1 gave similar results to the microarray but IL1RN at D10,
and TGIF at D50 gave different results with the two technologies.
4. Discussion
The current study builds on our previous projects (Gossner
et al., 2011a,b; Gossner and Hopkins, 2014) using experimental
Table 4
Signiﬁcantly repressed differentially-expressed genes at D50.
Gene Gene name p value FC
MOXD1 Monooxygenase, DBH-like 1 0.0178 4.38
LTF Lactotransferrin 0.0400 2.46
CDH26 Cadherin 26 0.0418 2.44
CAMP Cathelicidin antimicrobial peptide 0.0457 2.43
CPNE4 Copine IV 0.0376 2.33
OR5R1 Olfactory receptor, family 5, subfamily R, member 1 0.0214 2.30
C11orf70 Chromosome 11 open reading frame 70 0.0452 2.24
TGIF1 TGFB-induced factor homeobox 1 0.0310 2.18
GABRQ Gamma-aminobutyric acid (GABA) A receptor, theta 0.0409 2.11
OR2T33 Olfactory receptor, family 2, subfamily T, member 33 0.0450 2.03
OR5P3 Olfactory receptor, family 5, subfamily P, member 3 0.0047 1.99
HEPH Hephaestin 0.0393 1.89
UNG Uracil-DNA glycosylase 0.0280 1.89
OAT Ornithine aminotransferase 0.0068 1.86
GSDMA Gasdermin A 0.0393 1.86
GREB1 Growth regulation by estrogen in breast cancer 1 0.0090 1.86
DPF3 D4, zinc and double PHD ﬁngers, family 3 0.0060 1.77
UQCRB Ubiquinol-cytochrome c reductase binding protein 0.0019 1.76
LDHC Lactate dehydrogenase C 0.0002 1.76
S100A6 S100 calcium binding protein A6 0.0243 1.74
C2orf70 Chromosome 2 open reading frame 70 0.0041 1.74
SPATS2 Spermatogenesis associated, serine-rich 2 0.0060 1.74
OR52H1 Olfactory receptor, family 52, subfamily H, member 1 0.0428 1.70
OR13C3 Olfactory receptor, family 13, subfamily C, member 3 0.0177 1.70
CTSG Cathepsin G 0.0151 1.69
SLC22A16 Solute carrier family 22, member 16 0.0405 1.69
SDHD Succinate dehydrogenase complex, subunit D, integral membrane protein 0.0132 1.68
CCDC172 Coiled-coil domain containing 172 0.0002 1.67
NTF4 Neurotrophin 4 0.0135 1.66
OR2F1 Olfactory receptor, family 2, subfamily F, member 1 0.0274 1.66
PGAM2 Phosphoglycerate mutase 2 (muscle) 0.0279 1.65
Gene Gene name p value FC
SLITRK4 SLIT and NTRK-like family, member 4 0.0007 1.64
OR8B3 Olfactory receptor, family 8, subfamily B, member 3 0.0490 1.64
LOC101105206 Olfactory receptor 12-like 0.0133 1.63
C10orf53 Chromosome 10 open reading frame 53 0.0431 1.62
FOLR1 Folate receptor 1 (adult) 0.0173 1.61
SOHLH2 Spermatogenesis and oogenesis speciﬁc basic helix-loop-helix 2 0.0128 1.61
ZC3H14 Zinc ﬁnger CCCH-type containing 14 0.0001 1.59
CETN1 Centrin, EF-hand protein, 1 0.0119 1.59
OR5H1 Olfactory receptor, family 5, subfamily H, member 1 0.0051 1.58
C12orf42 Chromosome 12 open reading frame 42 0.0428 1.58
GUCA1C Guanylate cyclase activator 1C 0.0062 1.58
PKIB Protein kinase (cAMP-dependent, catalytic) inhibitor beta 0.0362 1.58
OR5T1 Olfactory receptor, family 5, subfamily T, member 1 0.0106 1.57
SYBU Syntabulin (syntaxin-interacting) 0.0380 1.56
FTL Ferritin, light polypeptide 0.0439 1.55
OR5H2 Olfactory receptor, family 5, subfamily H, member 2 0.0241 1.55
CDA Cytidine deaminase 0.0054 1.55
NKAIN2 Na+/K+ transporting ATPase interacting 2 0.0020 1.53
DMD Dystrophin 0.0377 1.53
OR52D1 Olfactory receptor, family 52, subfamily D, member 1 0.0149 1.53
DACH2 Dachshund family transcription factor 2 0.0304 1.53
DSG1 Desmoglein 1 0.0191 1.52
MAG Myelin associated glycoprotein 0.0401 1.52
C9orf135 Chromosome 9 open reading frame 135 0.0242 1.52
C14orf79 Chromosome 14 open reading frame 79 0.0392 1.52
LRRC48 Leucine rich repeat containing 48 0.0468 1.52
RAB44 RAB44, member RAS oncogene family 0.0432 1.52
CRYGA Crystallin, gamma A 0.0100 1.51
EPB42 Erythrocyte membrane protein band 4.2 0.0425 1.51
PDCL2 Phosducin-like 2 0.0030 1.51
OR8S1 Olfactory receptor, family 8, subfamily S, member 1 0.0146 1.51
Genes with fold change (FC) 1.5 fold and adjusted p value of 0.05.
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sheep, and aims to identify the physiological processes triggered
by SSBP/1 scrapie infection of peripheral lymph nodes at time
points immediately before (D10) and after (D50) the detection of
PrPSc by immunohistochemistry. These lymph nodes consistlargely of lymphocytes that constantly trafﬁc through the node;
and there are no discernible changes to histology and/or cell
content between the uninfected, D10 and D50 lymph nodes
(Gossner et al., 2011b). However PrPSc accumulates and replicates
in FDCs (McCulloch et al., 2011). Consequently the transcriptome
Table 5
Top diseases and disorders Bio-Functions at D10 and D50 identiﬁed by IPA.
D10 vs. C p value
Gastrointestinal disease 5.06E-04–4.62E-
02
CYP3A5, IL1RN, LRRC15, ADM, HNF4A, MOGAT2, MOGAT3, HTR3A, HLA-DQA1
Organismal injury and abnormalities 5.06E-04–4.57E-
02
CYP3A5, IL1RN, LRRC15, ADM, HTR3A, NEFL, FKBP14, LIPN, SEPT5, RASGRF2, MAG
Neurological disease 2.55E-03–4.96E-
02
ADM, HTR3A, IL1RN, ATCAY, NEFL, FKBP14, SEPT5, ZBTB16, MAG, RPL10, TRMT2A, HNF4A, BRINP1, HLA-DQA1, IER3,
RASGRF2
D50 vs. C p value
Neurological disease 1.74E-04–4.07E-02
MAG, MAL, FTL, FOLR1, TGIF1, HMGB1, HEPH, NTF4
Inﬂammatory response 3.24E-04–4.77E-02
CAMP, HMGB1, CTSG, LTF, DMD
Connective tissue disorders 1.97E-03–4.14E-02
CAMP, HMGB1, CTSG, LTF, FLT, TGIF1, CDA, CDH26, GPR123, NTF4
Immunological disease 1.97E-03–3.40E-02
CAMP, CTSG, HMGB1, LTF, UNG, LYPLA2, DSG1, NTF4, S100A6, TMEM116, CDA, GPR123, CDH26
Inﬂammatory disease 1.97E-03–4.46E-02
FOLR1, CAMP, CTSG, HMGB1, LTF, FTL, DMD, NKAIN2, VNN2, CDA, GPR123, CDH26, NTF4
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determined by migrating lymphocytes responding to static, but
PrPSc-infected FDCs.
Inoculation of most infectious agents into the drainage area of a
lymph node induces a reaction to that agent; principally the
development of an adaptive immune response aimed at the
elimination or control of that infection. For most antigens this
response peaks at D5–D10 and resolves by D20 (Hall and Morris,
1965). Although scrapie infection does not seem to induce a
speciﬁc immune response to the agent (a misfolded self-antigen)
(Prusiner, 1982) or grossly affect the immunological function of the
lymph node (Heikenwalder et al., 2005), 75 genes were
signiﬁcantly differentially-expressed by 10 days after SSBP/
1 infection, in comparison to uninfected brain homogenate of
the same PRNP genotypes. None of the 75 genes were signiﬁcantly
differentially-expressed at D50. Similarly, none of the 80 genes
identiﬁed at D50 were changed signiﬁcantly at D10. However there
were several, e.g. IFI6 at D10 and MOXD1 at D50 that were
differentially-expressed at the other time point but p > 0.05. This
lack of obvious progression from D10 to D50 indicates a step
change in lymph node physiology coincident with PrPSc accumu-
lation and/or ampliﬁcation similar to that seen with SSBP/1 scrapie
in the CNS (Gossner and Hopkins, 2014).
Approximately 70% of differentially-expressed genes were
decreased in relation to uninfected controls at both time points,
indicating that general repression of transcription is an effect of
scrapie infection even before the detection of PrPSc by immuno-
histochemistry. However, the levels of differential expression
following scrapie infection were relatively modest; at D10 the
maximum increase was only 2.62 fold and the maximum
repression was 2.56 fold. At D50 the up-regulated genes varied
only from 1.50 to 1.7 and the down-regulated genes from 1.51 to
4.48 fold. These data may indicate a general development of an
anti-inﬂammatory response from D10 to D50, which conﬁrms the
conclusions from our preliminary study (Gossner et al., 2011b) on
lymph node and spleen at the later D75 time point. The recently
study (Filali et al., 2014) on mesenteric lymph node (MLN) of
naturally-infected sheep also reported that the majority of
differentially-expressed genes were repressed.
At D10 the top Bio-Functions were gastrointestinal and
neurological disease; however some of the most signiﬁcantly-
increased genes have anti-inﬂammatory functions largelyconcerned with the blockade or inhibition of the major pro-
inﬂammatory cytokines. Adrenomedullin (ADM, +2.30 fold) has a
reciprocal relationship with IL-1b, IL-6 and TNFa (Koo et al., 2000);
interleukin 1 receptor antagonist (IL1RN, +1.52 fold) speciﬁcally
blocks IL-1a and IL-1b signalling (Arend et al., 1998) and
immediate early response 3 (IER3, +1.6 fold) protect cells from
TNFa and Fas-stimulated apoptosis (Wu, 2003). These inﬂamma-
tory antagonists are usually released to regulate acute inﬂamma-
tion (Arend et al., 1998); however D10 was the earliest time point
after SSBP/1 inoculation and we do not know if inﬂammation is an
acute response to scrapie infection. In addition, some of the most
signiﬁcantly repressed genes are positively-associated with
inﬂammation in other diseases. Leucine rich repeat containing
15 (LRRC15, -1.59 fold) is highly raised in caries-induced
inﬂammation (Dolan et al., 2007); 5-hydroxytryptamine (seroto-
nin) receptor 3A, ionotropic (HTR3A, -1.73 fold) increases the
inﬂammatory effect of peripheral serotonin (Duerschmied et al.,
2013) and neuroﬁlament, light chain polypeptide (NEFL, -1.66 fold)
is associated with inﬂammatory dysfunction driven by mitochon-
drial stress (Rossignol and Frye, 2014).
At D50 the top Bio-Functions were more obviously inﬂamma-
tion and immune response related, and major pro-inﬂammatory
genes were repressed, including the anti-microbial cathelicidins
CAMP, 2.33 fold (CATHL3 in the sheep annotation) and CATHL1B
(2.54 but p > 0.05) and the inﬂammatory peptidase, cathepsin G
(CTSG, 1.69 fold). CATHL1B was also found to be signiﬁcantly
repressed in MLN at the preclinical stage of natural scrapie (Filali
et al., 2014). Several other genes linked with either oxidative or ER
stress-associated inﬂammation are also down-regulated including
transforming growth factor, homeobox 1 (TGIF1, 2.18) and
dystrophin (DMD, 1.53). However, some adaptive immune-
related genes were increased at D50 including T cell differentiation
protein (MAL, +1.58 fold) and high-mobility group box1 (HMGB1,
+1.5 fold), which is a cofactor for RAG during VDJ recombination of
immunoglobulin and T cell receptor genes and binds to TLR4 as an
endogenous danger signal (Klune et al., 2008). Two other
immunologically-relevant genes were also increased but with p
values > 0.05. HLA-DQA (+15.91 fold at D10, +7.93 fold at D50) is
expressed by macrophages, B cells and activated T cells (Hopkins
et al., 1993); and activation-induced cytidine deaminase (AICDA,
+2.78 fold) is involved in somatic hypermutation and therefore
antigen-induced B cell maturation.
Fig. 1. Relative expression of selected genes in the D10, D50 and uninfected
control sample groups. RT-qPCR array results shown are the average DCq for
the gene of interest (GOI) calculated using the following formula DCq =
Cq(GOI) Cq(geometricmeanofthereferencegenes). The mean for the animals in each group
are shown with the error bars showing the standard deviation. Samples with the
highest mRNA expression levels for a gene have the lowest DCq values. Circles
Table 6
Comparison of D10 and D50 fold-change data from microarrays and RT-qPCR.
Gene D10 D50
Microarray RT-qPCR Microarray RT-qPCR
FC p value FC p value FC p value FC p value
ADM 2.3 0.0482 1.34 0.232 1.05 0.8915 1.32 0.244
CDH26 1.54 0.2594 1.59 0.1593 2.44 0.0418 1.77 0.154
HMGB1 1.29 0.1249 1.53 0.712 1.50 0.0279 2.2 0.403
IFI6 2.62 0.0422 2.19 0.14 1.54 0.2912 2.81 0.055
IL1RN 1.52 0.0337 1.66 0.22 1.05 0.7716 1.26 0.068
MOXD1 1.67 0.3023 1.76 0.29 4.38 0.0178 2.27 0.063
TGIF 1.04 0.8856 1.68 0.013 2.18 0.0310 1.13 0.376
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TSE diseases is associated with transition metal imbalance and a
reduction in antioxidant activity (Thackray et al., 2002). PrPC is a
copper-binding molecule with anti-oxidant activity that protects
cells from oxidative stress, and that low ferrous iron levels increase
oxidative stress (Fernaeus et al., 2005). The reduction in expression
of genes associated with transition metal metabolism was a
consistent pattern at D50, and indicates an imbalance in copper
and iron levels in sheep scrapie pathogenesis in lymphoid tissue.
Ferritin, light chain (FTL, 1.55,) and lactotransferrin (LTF, 2.46,)
play important roles in iron storage and homeostasis and are also
increased during inﬂammation (Tran et al., 1997). Hephaestin
(HEPH, 1.89,) is a multicopper oxidase that is involved in both
copper and iron transport and homeostasis (Grifﬁths et al., 2005);
and monoxygenase, DBH-like 1 (MOXD1, 4.38,) is copper-binding
enzyme and part of the catecholamine pathway and reduced
expression could lead to lower levels of dopamine and epineph-
rine, indicating possible consequent depression (Prigge et al.,
2000). In addition, the chemokines CCL26 (2.77 fold) and CCL3L1
(2.84 fold), are major regulators of inﬂammation that promote
eosinophil/basophil and lymphocyte/monocyte recruitment re-
spectively (Grifﬁth et al., 2014), were also repressed at D50 but
with p values > 0.05.
There are two major conclusions from this study. Firstly, scrapie
infection of the lymph node leads to the general down-regulation
of genes and in particular is associated with the repression of
inﬂammation at both D10 and D50. This contrasts with the effects
of sheep scrapie-infection in the CNS, where studies (Filali et al.,
2012; Gossner and Hopkins, 2014; Xiang et al., 2004) showed
consistent increases in genes promoting complement ﬁxation,
inﬂammation and cell death/apoptosis as well as regulation of cell
growth/cancer. Secondly, lymph nodes react to scrapie agent as
early as 10 days after infection and this reaction is not related to the
detectable accumulation of PrPSc. An additional intriguing contrast
in the response of the two tissues to SSBP/1 infection is the change
in expression of olfactory receptor genes; in the CNS the majority
are increased after infection while in peripheral lymphoid tissues
only two are increased (at D10) and 19 are repressed (6 at day
10 and 13 at D50). These almost certainly represent the expression
of non-functional pseudogenes within the lymph node (Zhang
et al., 2007). However, as with the CNS in sheep scrapie, there
seems to be no progression of events within the lymph node, from
the early D10 time point to the later D50; which is consistent with
gene expression changes in the MLN of preclinical and clinically-
affected sheep (Filali et al., 2014). This implies that the alterations
in gene expression reported in this current study are associated
more with progression of disease rather than accumulation of
PrPSc.represent the D10 samples (D10); squares represent the D50 samples (D50) and
triangles represent the uninfected control samples (C).
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